Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FUT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
U2AF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRAID - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF689 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCSK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRTC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on